These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28479019)

  • 1. Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting.
    Klepser DG; Klepser ME; Smith JK; Dering-Anderson AM; Nelson M; Pohren LE
    Res Social Adm Pharm; 2018 Apr; 14(4):356-359. PubMed ID: 28479019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a community pharmacy-based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing.
    Klepser DG; Klepser ME; Murry JS; Borden H; Olsen KM
    J Am Pharm Assoc (2003); 2019; 59(6):872-879. PubMed ID: 31474527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacist-physician collaborative streptococcal pharyngitis management program.
    Klepser DG; Klepser ME; Dering-Anderson AM; Morse JA; Smith JK; Klepser SA
    J Am Pharm Assoc (2003); 2016; 56(3):323-329.e1. PubMed ID: 27067554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
    Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
    J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting.
    Kirby J; Mousa N
    J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program.
    Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A
    J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility service evaluation of screening and treatment of group A streptococcal pharyngitis in community pharmacies.
    Thornley T; Marshall G; Howard P; Wilson AP
    J Antimicrob Chemother; 2016 Nov; 71(11):3293-3299. PubMed ID: 27439523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid antigen test use for the management of group A streptococcal pharyngitis in community pharmacies.
    Demoré B; Tebano G; Gravoulet J; Wilcke C; Ruspini E; Birgé J; Boivin JM; Hénard S; Dieterling A; Munerol L; Husson J; Rabaud C; Pulcini C; Malblanc S
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1637-1645. PubMed ID: 29876774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation of a Pharmacist-Conducted Group A Streptococcal Pharyngitis Point-of-Care Test: A Time and Motion Study.
    Corn CE; Klepser DG; Dering-Anderson AM; Brown TG; Klepser ME; Smith JK
    J Pharm Pract; 2018 Jun; 31(3):284-291. PubMed ID: 28553774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness.
    Klepser ME; Klepser DG; Dering-Anderson AM; Morse JA; Smith JK; Klepser SA
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):14-21. PubMed ID: 26802915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological point of care testing before antibiotic prescribing in primary care: considerable variations between practices.
    Haldrup S; Thomsen RW; Bro F; Skov R; Bjerrum L; Søgaard M
    BMC Fam Pract; 2017 Jan; 18(1):9. PubMed ID: 28125965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.
    Weber NC; Klepser ME; Akers JM; Klepser DG; Adams AJ
    Expert Rev Mol Diagn; 2016; 16(2):253-64. PubMed ID: 26560318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
    Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB
    J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records.
    Mantzourani E; Wasag D; Cannings-John R; Ahmed H; Evans A
    J Antimicrob Chemother; 2022 Dec; 78(1):84-92. PubMed ID: 36272134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a patient-reported outcome measure for children with streptococcal pharyngitis.
    Shaikh N; Martin JM; Casey JR; Pichichero ME; Wald ER; Colborn DK; Gerber MA; Kearney DH; Balentine TL; Haralam MA; Hoberman A
    Pediatrics; 2009 Oct; 124(4):e557-63. PubMed ID: 19786423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point of care testing for group A streptococci in patients presenting with pharyngitis will improve appropriate antibiotic prescription.
    Orda U; Mitra B; Orda S; Fitzgerald M; Gunnarsson R; Rofe G; Dargan A
    Emerg Med Australas; 2016 Apr; 28(2):199-204. PubMed ID: 26934845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notes from the Field: Group A Streptococcal Pharyngitis Misdiagnoses at a Rural Urgent-Care Clinic--Wyoming, March 2015.
    Harrist A; Van Houten C; Shulman ST; Van Beneden C; Murphy T
    MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1383-5. PubMed ID: 26719990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of diagnosis of streptococcal pharyngitis among Thai community pharmacists according to the Centor criteria.
    Saengcharoen W; Jaisawang P; Udomcharoensab P; Buathong K; Lerkiatbundit S
    Int J Clin Pharm; 2016 Oct; 38(5):1318-25. PubMed ID: 27573720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoepidemic of streptococcal pharyngitis in a hospital pharmacy.
    Karchmer TB; Anglim AM; Durbin LJ; Farr BM
    Am J Infect Control; 2001 Apr; 29(2):104-8. PubMed ID: 11287878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management and patient persistence with antibiotic course in suspected group A streptococcal pharyngitis for primary prevention of rheumatic fever: the perspective from a New Zealand emergency department.
    Mathan JJ; Ekart J; Houlding A; Payinda G; Mills C
    N Z Med J; 2017 Jun; 130(1457):58-68. PubMed ID: 28617790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.